Aurora Cannabis Inc., in collaboration with German healthcare technology leader Copeia, announced the launch of the English-language version of the Physician Experience Platform (PEP). This platform serves as a peer-to-peer educational resource for physicians, providing access to over 130 anonymized case studies on medical cannabis use in patient care.
The English PEP follows the successful rollout of its German counterpart in early 2024, aiming to provide healthcare professionals worldwide with clinical insights into cannabis-based therapies. Each case study includes detailed information such as patient history, treated symptoms, therapeutic outcomes, and dosage data.
Initially available to physicians in Canada, the United Kingdom, Poland, Malta, the Czech Republic, Australia, and New Zealand, the platform is designed to address challenges in medical cannabis prescribing due to limited integration into traditional healthcare education. A future version is expected to allow physicians globally to upload and share case studies, fostering international clinical collaboration.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.